MAXIMUS, Inc. (NYSE:MMS) – Analysts at KeyCorp cut their FY2018 earnings per share (EPS) estimates for MAXIMUS in a research note issued on Wednesday. KeyCorp analyst J. Gurda now forecasts that the health services provider will post earnings of $3.22 per share for the year, down from their prior forecast of $3.33. KeyCorp currently has a “Sector Weight” rating on the stock. KeyCorp also issued estimates for MAXIMUS’s FY2019 earnings at $3.52 EPS.

Several other research analysts have also recently issued reports on the company. ValuEngine cut MAXIMUS from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Jefferies Group LLC reiterated a “buy” rating and issued a $64.00 price target (down previously from $65.00) on shares of MAXIMUS in a research report on Thursday, February 16th. Maxim Group downgraded MAXIMUS from a “buy” rating to a “hold” rating and set a $66.00 price objective for the company. in a research note on Thursday, May 4th. They noted that the move was a valuation call. Canaccord Genuity reissued a “buy” rating and issued a $62.00 price objective on shares of MAXIMUS in a research note on Friday, April 7th. Finally, Zacks Investment Research downgraded MAXIMUS from a “hold” rating to a “sell” rating in a research note on Friday, February 10th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the stock. MAXIMUS has a consensus rating of “Hold” and an average price target of $61.33.

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

ILLEGAL ACTIVITY WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/05/26/analysts-set-expectations-for-maximus-inc-s-fy2018-earnings-mms.html.

Shares of MAXIMUS (NYSE:MMS) traded down 0.05% during midday trading on Friday, hitting $62.35. 126,732 shares of the company were exchanged. The company has a 50-day moving average price of $61.25 and a 200-day moving average price of $58.32. MAXIMUS has a 52-week low of $43.69 and a 52-week high of $64.25. The stock has a market capitalization of $4.04 billion, a price-to-earnings ratio of 20.44 and a beta of 1.13.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings data on Thursday, May 4th. The health services provider reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.02. MAXIMUS had a net margin of 8.08% and a return on equity of 26.42%. The firm had revenue of $622 million during the quarter, compared to analyst estimates of $620.24 million. During the same quarter in the prior year, the firm posted $0.74 earnings per share. MAXIMUS’s quarterly revenue was up 2.6% on a year-over-year basis.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 31st. Stockholders of record on Monday, May 15th will be paid a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, May 11th. MAXIMUS’s dividend payout ratio (DPR) is presently 5.98%.

In other news, CEO Richard A. Montoni sold 30,000 shares of the firm’s stock in a transaction dated Thursday, March 9th. The stock was sold at an average price of $60.59, for a total transaction of $1,817,700.00. Following the completion of the sale, the chief executive officer now directly owns 614,114 shares of the company’s stock, valued at approximately $37,209,167.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Russell A. Beliveau sold 1,500 shares of the firm’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $63.82, for a total value of $95,730.00. Following the sale, the director now directly owns 41,829 shares of the company’s stock, valued at $2,669,526.78. The disclosure for this sale can be found here. Insiders have sold a total of 126,407 shares of company stock valued at $7,839,076 over the last ninety days. Company insiders own 3.10% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of MMS. Mutual of America Capital Management LLC raised its position in shares of MAXIMUS by 0.7% in the third quarter. Mutual of America Capital Management LLC now owns 103,103 shares of the health services provider’s stock worth $5,832,000 after buying an additional 707 shares in the last quarter. Allegis Investment Advisors LLC raised its stake in MAXIMUS by 4.9% in the third quarter. Allegis Investment Advisors LLC now owns 24,136 shares of the health services provider’s stock worth $1,365,000 after buying an additional 1,117 shares during the period. Principal Financial Group Inc. raised its stake in MAXIMUS by 4.1% in the third quarter. Principal Financial Group Inc. now owns 252,222 shares of the health services provider’s stock worth $14,266,000 after buying an additional 10,041 shares during the period. Profund Advisors LLC raised its stake in MAXIMUS by 25.6% in the third quarter. Profund Advisors LLC now owns 11,559 shares of the health services provider’s stock worth $654,000 after buying an additional 2,358 shares during the period. Finally, Citadel Advisors LLC acquired a new stake in MAXIMUS during the third quarter worth about $546,000. 98.74% of the stock is currently owned by institutional investors and hedge funds.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

12 Month Chart for NYSE:MMS

Receive News & Ratings for MAXIMUS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.